About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, January 26th, 2015

The QualityStocks
Daily Stock List


United Cannabis Corp. (CNAB)

SmallCapVoice, TheMicrocapNews, and Greenbackers reported on United Cannabis Corp. (CNAB), and we report on the Company today, here at the QualityStocks Daily Newsletter.

United Cannabis Corp. established to provide leadership for the medical cannabis industry. This is through offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits via the use of cannabis-based research, products, and services. A bio cannabinoid technologies enterprise, the Company is built on scientific research, product development, and the implementation of its unique proprietary cannabinoid therapy program. Its’ A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a total solution, designed to enable physicians and patients to design, implement and monitor effective therapy protocols. 

The Company, with its consulting services, management and oversight, can assist any Cannabis oriented company on any scale. It is presently partnering nationally and internationally with local businessmen, entrepreneurs, and scientists to promote Best Practices in Planning, Procedures, Governance and Patient Care. It has access to a prolific catalog of award winning genetics. This includes more than 15 unique CBD dominant strains.

United Cannabis’ proprietary full spectrum cannabinoid program, A.C.T. Now has successfully helped thousands of patients via the Company’s oversight, its genetics network, and the use of its cultivation methods to grow hundreds of medical grade cannabis strains.

The Company will provide the science and methodologies needed to assist every legal cannabis operation with each aspect of the business. This covers the spectrum from facility design & construction, cultivation & production, to marketing, branding, wholesale, retail, and patient care. 

In jurisdictions where it is legal, the Company will enter into agreements with domestic and global partners who desire to license United Cannabis’ Intellectual Property (IP) and benefit from its consultation services.  Its consultation services provide current and future cannabis operations with “seed-to-sale” technologies based on previous success and proven results.

United Cannabis announced in September 2015 that it entered into a farm lease with INTIVA Real Estate Colorado LLC on an 80-acre property in Pueblo County, Colorado. The companies will work jointly to develop the property optimizing it for the growing, cultivation, and/or processing of marijuana. Moreover, United Cannabis announced this past October that it participated with a small group of Jamaicans to form a Jamaican corporation called Cannabinoid Research & Development Company Limited (CRD). United Cannabis owns a 50 percent interest in CRD. It participated in the formation of CRD to further its mission of advancing the use of cannabis in medical therapies via biomedical and pharmaceutical research and development, within Jamaica.

Recently, United Cannabis announced that its wholly-owned subsidiary, UC Nevada LLC, is the managing partner and minority shareholder in a group that has received provisional licenses for the cultivation, production and processing of cannabis in Clark County, Las Vegas, Nevada. UC Nevada’s intention is to begin operations as soon as possible. Furthermore, this month, United Cannabis announced that it signed a consulting and licensing agreement with FoxBarry Farms. FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the State of California.

United Cannabis Corp. (CNAB), closed Monday's trading session at $1.84, up 15.00%, on 101,470 volume with 180 trades. The average volume for the last 60 days is 55,603 and the stock's 52-week low/high is $0.0525/$11.45.

WindStream Technologies, Inc. (WSTI)

PHUB News, Hot Stock Profits, DSR News, Value Penny Stocks, Winston Small Cap, Impressive Penny Stocks, Pennystocktweeters.com, Fortune Stock Alerts, Penny Stock Circle, StockMarketQuote.us, StockMister, and FOX Penny Stocks reported on WindStream Technologies, Inc. (WSTI), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

WindStream Technologies, Inc. formed to create low-cost hybrid, renewable energy solutions for urban, suburban, and on and off-grid environments. The OTCQB listed Company’s patented SolarMill® technology is a distributed energy solution. SolarMill® produces continuous renewable energy for customers 24/7, 365 days a year. Founded in 2008, WindStream Technologies has its corporate headquarters in North Vernon, Indiana.  

The Company established with the goal of designing, prototyping, and manufacturing affordable and scalable renewable energy technologies for the global market. It has developed and tested the first-of-its-kind, integrated, hybrid energy solution. WindStream Technologies is now marketing and selling the SolarMill® (made in the U.S.) to an international customer base. Its patented SolarMill® products consist of Vertical Axis Turbines and Solar Panels controlled by WindStream's proprietary "smart" electronics.

WindStream has set up its India/South Asia Operations under the name of WindStream Energy Technologies, Pvt. Ltd. This is with the objective of serving that area with products manufactured in India under the close inspection of WindStream USA.  WindStream Technologies will continue to manufacture and ship its products worldwide from its facilities in Indiana.

WindStream had its official launch of the proprietary WindStream UPS eMPOWER system for Jamaica Public Services (JPS) in May 2014. In June 2014, WindStream signed several new distribution agreements. This expands its reach into new territories around the world to include Turkey, Netherlands, New Zealand, Ghana, Liberia, Kenya, and Tanzania.

This past December, WindStream Technologies announced that it closed a Joint Venture (JV) agreement with West Coast Ventures (India) Pvt. Ltd., (WCV) based in Chennai, India and a group of strategic investors. The new entity, DEEPAN Energy Venture LLP, has committed $2 million dollars for an equity stake in the JV, which will form a manufacturing and distribution presence in India and South Asia.

Earlier this month, WindStream Technologies announced that it broke ground on its 50,000 sq. ft. manufacturing facility outside of Hyderabad, India. The new facility will be the Company's second manufacturing plant focused on building its proprietary SolarMill®products and designed to service the India and South Asia markets. The new. facility will be built to the specifications of WindStream Technologies Energy India, Pvt. Ltd. It will reflect WindStream’s first facility in North Vernon, Indiana. The Company’s expectation is to produce a minimum of 5000 SolarMills in 2015 and see that number grow as process and procedures are refined and improved upon. 

WindStream Technologies, Inc. (WSTI), closed Monday's trading session at $0.15, up 1.69%, on 146,194 volume with 25 trades. The average volume for the last 60 days is 228,777 and the stock's 52-week low/high is $0.10/$2.25.

Mountain High Acquisitions Corp. (MYHI)

TopPennyStockMovers, SmallCapVoice, Integrity Solution IR, Charms Investments LTD, FivedollarMovers.net, Wallstreet Profiler, and PennyDoctor reported on Mountain High Acquisitions Corp. (MYHI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Denver, Colorado based Mountain High Acquisitions Corp. is a strategic real estate holding company. Its chief emphasis is the acquisition and development of commercial properties to be leased and used by the marijuana industry. The Company’s current portfolio includes three Colorado properties zoned for commercial marijuana cultivation: Isabelle, Madison, and Pueblo. Mountain High Acquisitions lists on the OTC Market Group’s OTCQB.

The Company’s focus is to serve the marijuana industry as a landlord providing value-added, state-of-the-art facilities and services. Mountain High, through its wholly-owned subsidiary, Canna-Life Corp., is the current holder of purchase options on the three aforementioned real estate properties zoned by the State of Colorado and municipal authorities for the cultivation of marijuana. The Company does not, and will not grow, harvest, distribute, or sell cannabis or any substances that violate U.S. law or the Controlled Substances Act. It has no intention to do so in the future.  

Mountain High’s tenants are licensed growers. The State of Colorado limits the number of commercial marijuana growers’ licenses. As a result, the market of available tenants is tightly controlled and well understood. Presently, Mountain High believes existing demand from the licensed growers with whom it is in contact is more than adequate to fill any vacancy on its properties.

Mountain High Acquisitions announced in 2014 that Canna-Life completed the definitive Master Property Purchase and Sale Agreement for the acquisition of three properties and improvements located in Lafayette, Boulder County, Colorado, referred to as the Isabelle Property; Avondale, Pueblo County, Colorado, referred to as the Pueblo Property; and Denver, Denver County, Colorado, referred to as the Madison St. Property.

Mountain High signed a Letter-of-Intent (LOI) to acquire property and related structures in Pueblo, Colorado. The 2.38 acre parcel of industrial land has been zoned by the State of Colorado and municipal authorities for the cultivation of marijuana and preparation of marijuana related products.

In September 2014, Mountain High announced that it completed all pre-closing due diligence regarding its previously announced LOI to acquire the 2.38 acre property and related structures in Pueblo, Colorado, known as the Greenhorn Property. The property presently holds an approximately 2,800 sq. ft. industrial use structure.

Mountain High Acquisitions Corp. (MYHI), closed Monday's trading session at $0.14, down 17.65%, on 93,616 volume with 9 trades. The average volume for the last 60 days is 61,914 and the stock's 52-week low/high is $0.021/$15.00.

Titan Pharmaceuticals, Inc. (TTNP)

PennyStocks24, Penny Pick Finders, PennyStockProphet, SecretStockPromo, StockOnion, Planet Penny Stocks, Buzz Stocks, and SmarTrend Newsletters reported earlier on Titan Pharmaceuticals, Inc. (TTNP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in South San Francisco, California. It is developing proprietary therapeutics principally for the treatment of central nervous system (CNS) disorders. The Company’s main asset is Probuphine®. This product is the first slow-release implant formulation of buprenorphine hydrochloride (buprenorphine). Titan Pharmaceuticals lists on the OTC Bulletin Board.

Probuphine® is the first product to utilize ProNeura™ - a novel, proprietary, long-term drug delivery technology. The ProNeura™ technology has the potential to be used in developing products for the treatment of other chronic conditions, such as Parkinson's disease. The Probuphine New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) in October of 2012 - seeking approval for the treatment of opioid dependence.

The design of Probuphine® is to maintain a stable, round-the-clock blood level of the medicine in patients for up to six months following a single treatment. A seven-day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in the U.S. in 2011. Probuphine® is an investigational subdermal implant for the maintenance treatment of opioid dependence in adult patients. Titan Pharmaceuticals’ objective is to enter into one or more collaborations with capable pharmaceutical companies to commercialize Probuphine® in the U.S. and international markets, and to develop, potentially, the product for the treatment of chronic pain.

Moreover, Titan Pharmaceuticals is entitled to royalty revenue of 8-10 percent of net sales of Fanapt® (iloperidone). This is an atypical antipsychotic compound being marketed in the U.S. for the treatment of schizophrenia by Novartis Pharma AG under a sub-license agreement based on a licensed U.S. patent that expires in October 2016 (does not include a possible six month pediatric extension).

In November 2014, Titan Pharmaceuticals announced completion of enrollment in the ongoing Phase 3 study of Probuphine®, its investigational subdermal implant for the maintenance treatment of opioid dependence. Study completion is expected to be on schedule by the middle of 2015, paving the way for resubmission of the New Drug Application (NDA) for Probuphine with the U.S. FDA later in 2015. The Company’s partner, Braeburn Pharmaceuticals, is sponsoring the study.

Titan Pharmaceuticals, Inc. (TTNP), closed Monday's trading session at $0.505, up 2.86%, on 3,192,515 volume with 432 trades. The average volume for the last 60 days is 222,133 and the stock's 52-week low/high is $0.44/$0.865.

Bitcoin Shop, Inc. (BTCS)

RedChip, SmallCapVoice, PennyStocks Forever, AddictivePennyStocks, PricelessPenny, PennyStockRumors.net, Bullseyestox.com, and TheMicrocapNews reported on Bitcoin Shop, Inc. (BTCS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin Shop, Inc. is the operator of the digital currency ecommerce marketplace www.btcs.com, which is undertaking the build-out of a universal digital currency ecosystem. The objective of this platform is to enable users to engage in the digital currency ecosystem via one point of access. The Company operates its public beta site (www.btcs.com) where consumers can buy products using digital currency including bitcoin, litecoin and dogecoin, through searching through a selection of more than 250,000 items. Bitcoin Shop is based in Arlington, Virginia. The Company’s shares trade on the OTC Market Group’ OTCQB.

The Company offers its customers competitive pricing options from 256 retailers by way of its "Intelligent Shopping Engine". All ecommerce customer orders are fulfilled by third party vendors. Bitcoin Shop’s plan is to use its ecommerce platform as a customer access point for a more extensive digital currency platform. Digital currencies use peer-to-peer networks to enable instant payments. They are categorized as cryptocurrencies because they utilize cryptography as a security measure. Digital currency issuances and transactions are carried out collectively by the network, and permit users to make verified transfers. There is no central authority.

Bitcoin Shop has been partnering with strategic digital currency companies (who have technologies, services or products that are complementary to Bitcoin Shops’ business strategy), via making investments in them and integrating with them.

Last week, Bitcoin Shop announced that it closed on financings for aggregate proceeds of $498,000. The Company also sold non-convertible promissory notes to Company co-founders, Michal Handerhan and Tim Sidie, for aggregate proceeds of $65,000. Furthermore, Bitcoin Shop made a follow-on investment of $100,000 in its strategic partner Coin Outlet. Through the strategic investment and partnership with Coin Outlet, Bitcoin shops plan is to take advantage of Coin Outlet's ATM network as an on-ramp to its planned universal digital currency ecosystem, which includes ATM/financial services.

Bitcoin Shop, Inc. (BTCS), closed Monday's trading session at $0.10, up 28.21%, on 2,108,580 volume with 317 trades. The average volume for the last 60 days is 287,856 and the stock's 52-week low/high is $0.0555/$5.26.

AV Therapeutics, Inc. (AVTH)

Red Chip, Real Pennies, and TheMicrocapNews reported on AV Therapeutics, Inc. (AVTH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB listed AV Therapeutics, Inc. is a developer of cancer therapeutics and vaccines. The Company is involved in the development of the chemotherapeutic drug Capridine and peptide mimotope-based Cancer Vaccines.  Its scientists have identified and patented Capridine, which has shown in preclinical models to have specific activity against prostate and colon cancer. AV Therapeutics has its corporate headquarters in New York, New York.

In preclinical trials in cell culture and xenograft models, Capridine was observed to have particular activity towards prostate cancer with low myelo-suppression. These activities placed Capridine in a unique category, none of which exists in the prostate cancer area, particularly for metastatic castrate resistant prostate cancer (CRPC).

The aim of AV Therapeutics’ Founders is that the therapeutic agents used will first eliminate the cancer and subsequently the immunotherapeutic peptides will be able to re-educate or reprogram the immune system to recognize micro-metastatic previously undetected cancer cells and eliminate them, thus eliminating the odds of recurrence and/or metastases.

AV Therapeutics’ plan is to enter into agreements with large pharmaceutical companies where the Company will enjoy an upfront cash sum, plus a continuing royalty stream when the drug/vaccine(s) are approved by the Food and Drug Administration (FDA) for use in the market. It will look for a partner(s) in early Phase II/III clinical trials of any particular treatment modality drug and/or vaccine.

Recently, AV Therapeutics announced the completion of GMP synthesis of its lead prostate cancer drug, Capridine. Analysis of the product indicated the Capridine to be 99.8 percent pure and NMR (nuclear magnetic resonance) analysis showed significant conformity of the scaled-up product. This achievement was possible with the assistance of the colleagues at Davos Pharma and the scientists at Anthem Biosciences, under the supervision and guidance of Dr. Raj Tiwari, Chief Scientific Officer of AV Therapeutics.

Dr. Abraham Mittelman, AV Therapeutics’ Chief Executive Officer, congratulated the team on having attained this feat in the shortest and cost effective manner. Dr. Mittelman also expressed satisfaction that AV Therapeutics can now take the next step toward clinical evaluation. He stated, "All of our previous data on the product is validated and this level of purity of the drug will go a long way in defining its clinical activity."

AV Therapeutics, Inc. (AVTH), closed Monday's trading session at $0.04, up 5.54%, on 59,370 volume with 6 trades. The average volume for the last 60 days is 84,613 and the stock's 52-week low/high is $0.0276/$0.89.

Ener-Core, Inc. (ENCR)

Greenbackers, Lions of Wall Street, PennyStocks24, TheMicrocapNews, StreetAuthority Financial, StockBlogs, ProfitableTrading, Dividend Opportunities, Investors Alley, and Trade of the Week reported earlier on Ener-Core, Inc. (ENCR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Ener-Core, Inc. is the world’s only provider of Power Oxidation technology and equipment, which produces clean power from low-quality waste gases from a wide variety of industries. The Company designs and manufactures innovative systems for producing continuous energy from a broad spectrum of sources. The Ener-Core Gradual Oxidizer is its patented oxidation technology. It enables the conversion of these gases into useful heat and power with the lowest known associated emissions. Ener-Core’s shares trade on the OTC Bulletin Board.

Irvine, California headquartered Ener-Core serves many markets worldwide. These markets include oil fields, biogas, coal mines, natural gas, emissions control, and utility power generation. The Company designs and manufactures unique and innovative systems that generate base load, clean power from a wide array of previously unusable waste gasses including methane.

Ener-Core offers systems with fuel flexibility and pollution control for power generation, with the Ener-Core Gradual Oxidizer matched to gas turbines. The Gradual Oxidizer can also undergo customization for integration with larger existing power generation systems to offer first-rate pollution control and achieve zero emissions.

The Company has developed the 250kW Ener-Core Powerstation EC250 (EC250), and its larger counterpart, the 2MW Ener-Core Powerstation KG2-3GEF/GO, to transform methane gas, especially "ultra-low-Btu gas" from landfills, coal mines, oil fields and other low quality methane sources into continuous clean electricity with near-zero emissions.

The specific engineering of the Powerstations are for fuel flexibility and modularity so that these low-Btu gas sources can be utilized as an energy resource instead of wasted through venting and/or flaring. The EC250 is a clean power generation solution using the Ener-Core Gradual Oxidation technology integrated with a 250 kW gas turbine.

Ener-Core announced this past November that it entered into a global licensing agreement with the Dresser-Rand Company. This is to develop and market the Dresser-Rand KG2-3GEF two-megawatt gas turbine coupled with the Ener-Core oxidizer. Dresser-Rand is among the globe’s largest suppliers of rotating equipment to the oil, gas petrochemical, and process industries. The license agreement grants Dresser-Rand exclusive rights to commercialize the Ener-Core 1-4MW MW Gradual Oxidizer bundled with the Dresser-Rand KG2 gas-turbine product line.

Last week, Ener-Core announced that it won the 2014 New Economy Award for Best Air and Environment Solutions which recognizes forerunners in the clean technology and renewable energy sectors.

Ener-Core’s Chief Executive Officer, Mr. Alain Castro, said, "We are honored to accept this award and pleased to be recognized for our work in establishing a solution to the world’s methane pollution problem. Ener-Core’s Power Oxidizer attacks air pollution at the source by turning low-quality methane into clean, base-load energy. Our solution empowers our customers to create significant operating efficiencies where they would otherwise find capital loss due to costly environmental regulations.”

Ener-Core, Inc. (ENCR), closed Monday's trading session at $0.15, up 0.67%, on 414,648 volume with 70 trades. The average volume for the last 60 days is 410,311 and the stock's 52-week low/high is $0.0741/$0.96.


The QualityStocks
Company Corner


Save The World Air, Inc. (ZERO)

The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.415, off by 0.53%, on 21,734 volume with 7 trades. The stock’s average daily volume over the past 60 days is 106,605, and its 52-week low/high is $0.3401/$1.10.

Save The World Air, Inc. today announced that Thomas A. Bundros has been elected as an independent member of its Board of Directors, effective Friday, January 23, 2015. "We're delighted to welcome Tom to our Board and believe our organization will benefit greatly from his valuable counsel and insight, especially given his leadership experience in the petroleum transportation sector," commented Greggory Bigger, STWA's Chief Executive Officer and Chairman. "He is well-known, highly accomplished, and has extensive industry relationships that will help us as we look to grow our assets and enhance shareholder value in both the short and long-term."

Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.

In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.

The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.

STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.

Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer

Save The World Air, Inc. Company Blog

Save The World Air, Inc. News:

STWA Appoints Energy Industry Executive Thomas A. Bundros to Board of Directors

STWA Issues Letter to Shareholders

STWA Upgrades to OTCQX(R) Marketplace

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.004, up 21.21%, on 7,218,346 volume with 74 trades. The stock’s average daily volume over the past 60 days is 3,953,462, and its 52-week low/high is $0.0008/$0.35.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

Vivica A. Fox Talks About Her Collaboration With The One World Doll Project

The One World Doll Project to Release Collectors Doll With Vivica A. Fox

The One World Doll Project Expands Retail Presence in Texas With Fiesta Mart

Pan Global Corp. (PGLO)

The QualityStocks Daily Newsletter would like to spotlight Pan Global Corp. (PGLO). Today, Pan Global Corp. closed trading at $0.0095, up 11.76%, on 5,500 volume with 3 trades. The stock’s average daily volume over the past 60 days is 85,094, and its 52-week low/high is $0.005/$0.28.

Pan Global Corp. (PGLO) is focused on building the world’s green economy by developing, building, owning, and operating the necessary infrastructure. Current opportunities are currently concentrated on developing projects in India, specifically in the areas of hydro-power generation, solar PV, geo-thermal, sustainable agriculture, and green construction.

The India growth story is frequently compared to China, which has sustained above-average annual growth for three decades, whereas India’s take-off growth began at a later stage. During the last decade, India’s growth has averaged approximately 8% per year. India is poised for high GDP growth that will be sustained for decades to come.

Within the Indian market there are available various government-backed incentives programs, including those which provide direct tariff subsidies as well as market-based tariff support through renewable energy credits. Assessing project viability on a case by case basis, Pan Global seeks to invest in projects both as owner-developers and/or as partners with other developers.

Pan Global’s business strategy is an extension of the company’s commitment to improve human well-being and social equity, while significantly reducing environmental risks and ecological scarcities. By developing a series of highly environmentally sustainable and high ROI projects, Pan Global aims to accelerate business growth. Disclaimer

Pan Global Corp. Company Blog

Pan Global Corp. News:

Pan Global, Corp. Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017

Pan Global, Corp. Shareholder Update: Small-Hydro Plant Connected to Power Grid in Northern India

Pan Global, Corp. Increases Equity Stake in 5.7 MW Small-Hydro Plant in Northern India

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.085, up 6.25%, on 968 volume with 2 trades. The stock’s average daily volume over the past 60 days is 2,088, and its 52-week low/high is $0.04/$0.5499.

Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Cleartronic, Inc. News:

Cleartronic Appoints Two New Members to Board of Directors

Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors

Cleartronic Announces License Agreement With Collabria LLC

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.03685, up 4.69%, on 108,610 volume with 22 trades. The stock’s average daily volume over the past 60 days is 110,408, and its 52-week low/high is $0.03/$2.00.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program

Start Scientific, Inc. (STSC)

The QualityStocks Daily Newsletter would like to spotlight Start Scientific, Inc. (STSC). Today, Start Scientific, Inc. closed trading at $0.2455, up 2.29%, on 14,440 volume with 10 trades. The stock’s average daily volume over the past 60 days is 33,772, and its 52-week low/high is $0.101/$0.68.

Operating from headquarters in San Antonio, Texas, Start Scientific, Inc. (STSC) is in continual and aggressive pursuit of its corporate objective to take advantage of oil and gas exploration and development opportunities that are overlooked by mid-sized oil and gas companies.

Start Scientific’s is focused on developing leases and/or joint venture partnerships for its four primary projects in Mississippi, Texas, North Dakota and West Virginia. The projects include shallow, deep, and horizontal drilling opportunities. Geographically, the projects offer the company diversity for exploration and drilling.

As a progressive oil exploration, drilling, extraction and delivery company, Start Scientific relies on the vast knowledge of its management team, which provides more than half a century of combined industry experience. Leveraging strong industry contacts established by company founder Norris R. Harris, Start Scientific also explores partnership and joint-venture opportunities to further accelerate its growth.

Supported by a management team highly experienced in the workings of natural resources and business development, Start Scientific is well-positioned to achieve its mission to explore low-risk land lease opportunities on properties with known oil deposits, develop facilities on these properties to cost effectively extract the oil, and to distribute the refined oil for sale in the open market. Disclaimer

Start Scientific, Inc. Company Blog

Start Scientific, Inc. News:

Start Scientific, Inc. Signs Farmout Agreement With Durban Energy

Start Scientific, Inc. Acquires Option to Purchase 1,500 Acres of Leases in Matagorda County, Texas

Start Scientific, Inc. Signs Farmout Agreement for Flora Field, Madison County, Mississippi

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.2246, up 1.11%, on 34,053 volume with 15 trades. The stock’s average daily volume over the past 60 days is 152,019, and its 52-week low/high is $0.15/$1.00.

Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.

The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.

Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.

Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer

Zenosense, Inc. Company Blog

Zenosense, Inc. News:

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial

Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible

Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Daily Stock Motion





By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251